Trial Profile
Phase II trial of tigecycline in patients with acute myeloid leukaemia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2013
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary)
- Indications Acute myeloid leukaemia; Bacterial infections
- Focus Therapeutic Use
- 29 Jul 2013 New trial record